Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer.

Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer.
复制标题

DOI:
10.3390/ijms15034031
复制
发表时间:
2014-03-05
影响因子:
5.6
通讯作者:
Liu ZB
Liu ZB
中科院分区:
生物学2区
文献类型:
--
作者:
Peng WZ;Ma R;Wang F;Yu J;Liu ZB

文献摘要

参考文献

被引文献

相似文献

胃癌(GC)是世界范围内最常见的癌症类型之一。因此,了解GC肿瘤发生的生物学对于适当的诊断和患者监测是重要的。miR-191/425簇已被报道在多种人类癌症中过表达,但miR-191/425过表达在胃癌发生中的致瘤作用和临床意义目前尚不明确。本研究检测胃癌组织和血清中miR-191和miR-425的表达,并分析其与临床病理资料的关系。我们发现miR-191和miR-425在人胃癌组织中相对于相邻的正常对照均显著增加。此外,miR-191水平与GC肿瘤分期和转移状态相关。此外,当使用血清miR-16作为内源性对照时,GC组中血清miR-191的水平显著高于对照组。最后,在GC细胞系HGC-27中抑制miR-191或miR-425不仅降低细胞增殖和细胞周期进展,而且损害细胞迁移和侵袭。综上所述,我们的研究结果揭示了miR-191和miR-425在胃癌发生中的致癌作用,并表明血清miR-191作为一种新的和稳定的胃癌诊断生物标志物的潜在用途。
Gastric cancer (GC) is among the most frequent types of cancer worldwide. Therefore, understanding the biology of GC tumorigenesis is important for appropriate diagnosis and patient surveillance. The miR-191/425 cluster has been reported to be overexpressed in various human cancers, but the tumorigenic role and clinical significance of miR-191/425 overexpression in gastric carcinogenesis is currently undefined. In this study, the expression of miR-191 and miR-425 in GC tissue and serum was assessed, and the relationship between miRNA expression and clinicopathological data was analyzed. We found that miR-191 and miR-425 were both significantly increased in human GC tissues relative to adjacent normal controls. In addition, miR-191 levels correlated with GC tumor stage and metastatic state. Furthermore, the level of serum miR-191 was significantly higher in the GC group than in the control group when using serum miR-16 as an endogenous control. Finally, inhibition of miR-191 or miR-425 in the GC cell lines HGC-27 not only reduced cell proliferation and cell cycle progression but also impaired cell migration and invasion. Taken together, our results revealed the oncogenic roles of miR-191 and miR-425 in gastric carcinogenesis, and indicated the potential use of serum miR-191 as a novel and stable biomarker for GC diagnosis.
DOI: 10.1158/0008-5472.can-10-1313
发表时间: 2010-10-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Elyakim, Eran;Sitbon, Einat;Yerushalmi, Noga
通讯作者: Yerushalmi, Noga
DOI: 10.1093/nar/gni178
发表时间: 2005-11-27
影响因子: 14.9
作者:
Chen C;Ridzon DA;Broomer AJ;Zhou Z;Lee DH;Nguyen JT;Barbisin M;Xu NL;Mahuvakar VR;Andersen MR;Lao KQ;Livak KJ;Guegler KJ
通讯作者: Guegler KJ
DOI: 10.1371/journal.pgen.1003311
发表时间: 2013
期刊: PLoS genetics
影响因子: 4.5
作者:
Di Leva G;Piovan C;Gasparini P;Ngankeu A;Taccioli C;Briskin D;Cheung DG;Bolon B;Anderlucci L;Alder H;Nuovo G;Li M;Iorio MV;Galasso M;Santhanam R;Marcucci G;Perrotti D;Powell KA;Bratasz A;Garofalo M;Nephew KP;Croce CM
通讯作者: Croce CM
鉴定血清 microRNA 作为胃癌早期检测的新型非侵入性生物标志物。
DOI: 10.1371/journal.pone.0033608
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Song MY;Pan KF;Su HJ;Zhang L;Ma JL;Li JY;Yuasa Y;Kang D;Kim YS;You WC
通讯作者: You WC
DOI: 10.1038/sj.bjc.6605608
发表时间: 2010-03-30
影响因子: 8.8
作者:
通讯作者: --